Interaction between the two subdomains of the C-terminal part of the botulinum neurotoxin A is essential for the generation of protective antibodies.
about
Characterization of botulinum neurotoxin type A neutralizing monoclonal antibodies and influence of their half-lives on therapeutic activityProduction and characterisation of a neutralising chimeric antibody against botulinum neurotoxin AFine and domain-level epitope mapping of botulinum neurotoxin type A neutralizing antibodies by yeast surface display.Neutralizing antibodies of botulinum neurotoxin serotype A screened from a fully synthetic human antibody phage display library.Characterization of the antibody response to the receptor binding domain of botulinum neurotoxin serotypes A and E.Preferential entry of botulinum neurotoxin A Hc domain through intestinal crypt cells and targeting to cholinergic neurons of the mouse intestineWhat next for botulism vaccine development?Bee Venom Phospholipase A2, a Good "Chauffeur" for Delivering Tumor Antigen to the MHC I and MHC II Peptide-Loading Compartments of the Dendritic Cells: The Case of NY-ESO-1.An atypical outbreak of food-borne botulism due to Clostridium botulinum types B and E from ham.Subunit vaccine efficacy against Botulinum neurotoxin subtypes.Development of human-like scFv-Fc antibodies neutralizing Botulinum toxin serotype BIsolation of nanomolar scFvs of non-human primate origin, cross-neutralizing botulinum neurotoxins A1 and A2 by targeting their heavy chain.Antigenic sites on the HN domain of botulinum neurotoxin A stimulate protective antibody responses against active toxinDNA vaccines targeting heavy chain C-terminal fragments of Clostridium botulinum neurotoxin serotypes A, B, and E induce potent humoral and cellular immunity and provide protection from lethal toxin challengeSubunit vaccine against the seven serotypes of botulismBacterial protein toxins and lipids: role in toxin targeting and activity.Evaluation of a recombinant Hc of Clostridium botulinum neurotoxin serotype F as an effective subunit vaccine.Generation of high-titer neutralizing antibodies against botulinum toxins A, B, and E by DNA electrotransfer.DNA electroporation in rabbits as a method for generation of high-titer neutralizing antisera: examples of the botulinum toxins types A, B, and EClostridial toxins.Translocation and dissemination to target neurons of botulinum neurotoxin type B in the mouse intestinal wall.Botulinum neurotoxin type B uses a distinct entry pathway mediated by CDC42 into intestinal cells versus neuronal cells.Recombinant botulinum neurotoxin A heavy chain-based delivery vehicles for neuronal cell targeting.Optimization of the BoNT/A-Hc expression in recombinant Escherichia coli using the Taguchi statistical method.Protein Structure Facilitates High-Resolution Immunological Mapping.Uptake of Clostridial Neurotoxins into Cells and Dissemination.C terminal half fragment (50 kDa) of heavy chain components of Clostridium botulinum type C and D neurotoxins can be used as an effective vaccine.
P2860
Q28475305-8DBA2C53-8834-4AB7-A663-B59382A7C9A2Q28475753-DD0B933E-09B5-4D8B-A70D-17B0A9577256Q33261279-2B352745-DB6F-4880-BD02-7C20943342B2Q33499630-14925BFF-A27A-49B1-9D95-98DECCCE9719Q34033221-E18F6790-1323-4A50-910C-AC9367DE6D7FQ34205889-508727EF-0B5A-47B8-94E3-08CB0AA4381FQ34343808-114485D2-1D01-4709-950A-2722883CE897Q34795079-26022711-B272-403A-90BF-640F742DC65BQ34983207-226A2153-AC0B-4603-A309-55828E02F05CQ35532054-637C192B-3C50-4532-9778-DA169461B990Q35779652-094287BB-7B8C-4179-B9CC-5CD0C0DE767EQ35780060-BDBDED5C-5BEE-45DD-BD93-13F3F194E0DBQ36217306-B7ED506B-439E-47C6-A8F6-82FE62BBA05BQ36256249-3D6052E3-7CCA-4E15-A831-A60FAAB969C3Q36483548-AEBAC824-D4D4-4FD9-85AF-87594B922A86Q36624085-D30F0001-AD83-4E59-B9A2-A77E3B34EEDDQ36994248-6EE1C1AF-8E10-454F-8535-373C5B40CA3CQ37191409-D00C23BB-C912-4327-AB61-A4EC6D944A34Q37530489-475345E8-8EF4-4493-B6EC-808A2730C09DQ37613674-D2A58118-D649-474A-A50D-C49E8C903BE7Q41040621-28C202F9-2E60-4D3B-AE7E-261370070A8DQ42506921-11AF8C31-5BAB-46DE-AC41-FDAE39FE97BEQ42600051-C981F50C-07AE-44D7-9D61-454D80E7359CQ43089033-B6F24747-176A-4B78-AB33-C880F62B0921Q47098544-ACA51E26-B43C-413E-879E-CF45B5A60729Q48124277-ED28D6ED-D2E7-4220-851D-35BAEA487B19Q54442858-42A0457B-6D78-40D4-99B3-3A7453B99B64
P2860
Interaction between the two subdomains of the C-terminal part of the botulinum neurotoxin A is essential for the generation of protective antibodies.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Interaction between the two su ...... tion of protective antibodies.
@en
type
label
Interaction between the two su ...... tion of protective antibodies.
@en
prefLabel
Interaction between the two su ...... tion of protective antibodies.
@en
P2093
P2860
P1433
P1476
Interaction between the two su ...... ation of protective antibodies
@en
P2093
Daniel Gillet
Jean Christophe Marvaud
Maria Manich
Maryse Gibert
Michel R Popoff
Stephanie Raffestin
Yannik Pereira
P2860
P304
P356
10.1016/J.FEBSLET.2004.06.094
P407
P577
2004-08-01T00:00:00Z